IRCCS Istituto Ortopedico Rizzoli, Laboratorio di Immunoreumatologia e Rigenerazione Tissutale, 40136 Bologna, Italy.
Biomolecules. 2020 Feb 21;10(2):340. doi: 10.3390/biom10020340.
Mesenchymal stem/stromal cells (MSCs) are a reservoir for tissue homeostasis and repair that age during organismal aging. Beside the fundamental in vivo role of MSCs, they have also emerged in the last years as extremely promising therapeutic agents for a wide variety of clinical conditions. MSC use frequently requires in vitro expansion, thus exposing cells to replicative senescence. Aging of MSCs (both in vivo and in vitro) can affect not only their replicative potential, but also their properties, like immunomodulation and secretory profile, thus possibly compromising their therapeutic effect. It is therefore of critical importance to unveil the underlying mechanisms of MSC senescence and to define shared methods to assess MSC aging status. The present review will focus on current scientific knowledge about MSC aging mechanisms, control and effects, including possible anti-aging treatments.
间充质干细胞(MSCs)是组织稳态和修复的储备库,会随着机体衰老而衰老。除了 MSC 的基本体内作用外,近年来它们也作为治疗多种临床疾病的极有前途的治疗剂出现。MSC 的使用通常需要体外扩增,从而使细胞暴露于复制性衰老中。MSC 的衰老(无论是体内还是体外)不仅会影响其复制潜能,还会影响其特性,如免疫调节和分泌谱,从而可能影响其治疗效果。因此,揭示 MSC 衰老的潜在机制并定义评估 MSC 衰老状态的共享方法至关重要。本综述将重点介绍关于 MSC 衰老机制、控制和影响的最新科学知识,包括可能的抗衰老治疗方法。